Cargando…
Inhibition of AKT survival pathway by a small molecule inhibitor in human endometrial cancer cells
The PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumour suppressor is mutated in 40–50% of human endometrial cancers. PTEN exerts its effects in part via inhibition of the antiapoptotic protein AKT. We demonstrate that two endometrial cancer cell lines that harbour PTEN mutations,...
Autores principales: | Jin, X, Gossett, D R, Wang, S, Yang, D, Cao, Y, Chen, J, Guo, R, Reynolds, R K, Lin, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410058/ https://www.ncbi.nlm.nih.gov/pubmed/15505622 http://dx.doi.org/10.1038/sj.bjc.6602214 |
Ejemplares similares
-
Incidence, mechanism and prognostic value of activated AKT in pancreas cancer
por: Schlieman, M G, et al.
Publicado: (2003) -
Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer
por: Holland, C M, et al.
Publicado: (2003) -
Tissue inhibitor of metalloproteinase-1 stimulates proliferation of human cancer cells by inhibiting a metalloproteinase
por: Porter, J F, et al.
Publicado: (2004) -
Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus
por: Kasamatsu, T, et al.
Publicado: (2003) -
Reduced expression of small GTPases and hypermethylation of the folate binding protein gene in cisplatin-resistant cells
por: Shen, D-W, et al.
Publicado: (2004)